COMMUNIQUÉ DE PRESSE publié le 23/07/2024 à 08:15, il y a 3 mois 29 jours EXEL Industries : Third quarter 2023–2024 sales up 2.1% EXEL Industries Group reports 2.1% revenue growth in Q3 2023-2024. Operational overview and 2023-2024 outlook in agricultural, leisure, and industry sectors Revenue Growth EXEL Industries Q3 2023-2024 Operational Overview 2023-2024 Outlook
BRÈVE publiée le 08/07/2024 à 18:38, il y a 4 mois 12 jours EXEL Industries : Nombre d'actions et de droits de vote au 30 juin 2024 Actions Règlement AMF Droit De Vote Mise À Jour Financière EXEL Industries
BRÈVE publiée le 08/07/2024 à 18:38, il y a 4 mois 12 jours EXEL Industries: Number of Shares and Voting Rights as of 30 June 2024 Voting Rights Shares Financial Update AMF Regulation EXEL Industries
COMMUNIQUÉ DE PRESSE publié le 08/07/2024 à 18:33, il y a 4 mois 12 jours EXEL Industries: Number of shares and voting rights as of 06.30.2024 EXEL Industries, a French Societe Anonyme with a share capital of €16,969,750, discloses its total number of shares and voting rights as per Article 223-16 of the AMF regulation Share Capital Voting Rights French Société Anonyme AMF Regulation EXEL Industries
BRÈVE publiée le 24/05/2024 à 08:04, il y a 5 mois 28 jours EXEL Industries : Résultats du premier semestre 2023-2024 Résultats Financiers Perspectives BAIIA EXEL Industries Revenu
BRÈVE publiée le 24/05/2024 à 08:04, il y a 5 mois 28 jours EXEL Industries: First Half 2023-2024 Results Financial Results EBITDA Revenue Outlook EXEL Industries
COMMUNIQUÉ DE PRESSE publié le 24/05/2024 à 07:59, il y a 5 mois 28 jours EXEL Industries: first half 2023–2024 results EXEL Industries reports a 2.0% revenue increase in the first half of 2023-2024, with EBITDA growing to €30.5 million. Net income remains stable at €4.7 million Financial Results Revenue Increase EBITDA Growth EXEL Industries Net Debt
BRÈVE publiée le 07/05/2024 à 20:35, il y a 6 mois 13 jours EXEL Industries détaille ses droits de vote et parts sociales au 30 avril 2024 Réglementation AMF EXEL Industries Droits De Vote EXEL Capitale Sociale Actions EXEL Industries
BRÈVE publiée le 07/05/2024 à 20:35, il y a 6 mois 13 jours EXEL Industries details its voting rights and shares as of April 30, 2024 AMF Regulations EXEL Industries EXEL Voting Rights Social Capital EXEL Industries Shares
COMMUNIQUÉ DE PRESSE publié le 07/05/2024 à 20:30, il y a 6 mois 13 jours EXEL Industries: Number of shares and voting rights as of 04.30.2024 EXEL Industries, a French Société Anonyme, discloses its total number of shares and voting rights as of April 30, 2024 in accordance with Article 223-16 of the AMF regulation Voting Rights Shares French Société Anonyme AMF Regulation EXEL Industries
Publié le 21/11/2024 à 06:58, il y a 7 heures 10 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 10 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 10 minutes Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 18 heures 1 minute Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 48 minutes Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 21/11/2024 à 13:30, il y a 38 minutes AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Publié le 21/11/2024 à 13:30, il y a 38 minutes Datametrex Secures Additional P.O. Approx $250K for IT Services
Publié le 21/11/2024 à 13:00, il y a 1 heure 8 minutes Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 1 heure 8 minutes Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 1 heure 8 minutes Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 13:41, il y a 27 minutes Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Publié le 21/11/2024 à 12:35, il y a 1 heure 33 minutes audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 53 minutes Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
